Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 02, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 24, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 01, 2017
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase IV
Recipient : Kaiser Permanente
Deal Size : Inapplicable
Deal Type : Inapplicable
Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 15, 2017
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Recipient : Kaiser Permanente
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase IV
Recipient : Sreedhar Mandayam
Deal Size : Inapplicable
Deal Type : Inapplicable
Ferric Citrate in ESRD Pilot Project
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
February 16, 2017
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Recipient : Sreedhar Mandayam
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase IV
Recipient : Winthrop University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of Ferric Citrate to Improve Inflammation and Lipid Levels
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
January 22, 2016
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Recipient : Winthrop University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Recipient : Denver Nephrologists, P.C.
Deal Size : Inapplicable
Deal Type : Inapplicable
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 08, 2015
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Recipient : Denver Nephrologists, P.C.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 20, 2014
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 01, 2014
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
November 29, 2012
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable